In the framework of the NanoResist TecnioSpring Industry project and the Mol4Bio project we received a visit from the "Tecnológico de Monterrey" in Mexico.
The meeting was organized to establish new collaborations and projects between the Tecnológico de Monterrey (Mexico) and the Nanomol-Bio Group at ICMAB, as a result of the Nano-Resist TecnioSpring Industry (Horizon 2020, MSCA grant agreement No. 801342 and the Government of Catalonia’s Agency for Business Competitiveness ACCIÓ) and the Mol4Bio (MCIN Plan Estatal) project.
The objective is to discover the potential of the ICMAB for the development of formulations of antiobesogenic molecules, new collaborations that allow the co-tutoring of postgraduate students and facilitate research stays for postgraduate students and postdoctoral students.
The researchers who came belong to the Institute for Obesity Research, recently created by the Tecnológico de Monterrey: Marco Rito-Palomares, Gerardo de Jesús García, Omar Lozano García, and Gustavo Adolfo Merino. They were welcomed and received by ICMAB Director Xavier Obradors, and Nora Ventosa, Imma Ratera and Karla Mayolo from the Nanomol-Bio research group at ICMAB, and Santi Sala, CEO of Nanomol Technologies.
Xavier Obradors, ICMAB Director, presenting the ICMAB to the Tecnológico de Monterrey members who visited us | ICMAB-CSIC
The project “Engineering novel peptide-based nanodelivery systems against antimicrobial resistance (Nano-Resist)” proposes multidisciplinary research that merges, organic, physical chemistry, materials science, and biotechnology to develop an alternative therapeutic strategy to conventional antibiotics to fight Antimicrobial Resistance (AMR) which is currently one of the main concerns of global health. The proposal aims to tackle bacterial resistant forms by an alternative anti-infective strategy that will directly target the bacterial signaling system and inhibit the bacterial community quorum sensing. Most antibiotics available in the market are based on pathogen virulence toxins.
The project is co-financied by Horizon 2020, Marie Skłodowska-Curie grant agreement No. 801342 and the Government of Catalonia’s Agency for Business Competitiveness (ACCIÓ) and developed at the Nanomol-Bio Group at ICMAB-CSIC with the collaboration of Tecnologico de Monterrey, Universitat Autònoma de Barcelona, Instituto de Investigaciones y Tecnologías Agroalimentarias, Nanomol Technologies and i-Vascular.
Members of the Tecnológico de Monterrey presenting their institute at the visit at ICMAB | ICMAB-CSIC
The project addresses two main biomedical challenges: supramolecular organizations for advanced therapies and novel molecular fluorescent materials for diagnosis (cancer biomarkers, intracellular temperature sensing, radical dendrimers as MRI contrast agents and materials for detection of electroactive biomolecules). The project is carried out by ICMAB researchers and with well-stablished collaborators with biologists, biochemists, clinicians and diagnostic instrumentalists, and R&D departments of private companies of the health sector.